US Deprescribing Research Network (USDeN)
Business Services · United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
United StatesRevenue
$14 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About US Deprescribing Research Network (USDeN)
The US Deprescribing Research Network (USDeN) aims to enhance medication use and outcomes for older adults through research on deprescribing. Funded by the US National Institute on Aging, it brings together a community focused on improving evidence-based practices in this area. The network offers resources for clinicians and researchers, as well as opportunities for stakeholder engagement and investigator development. Its activities include webinars, consultations, and annual meetings to foster collaboration and knowledge sharing.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is US Deprescribing Research Network (USDeN) your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if US Deprescribing Research Network (USDeN) is spiking on competitors!
US Deprescribing Research Network (USDeN), which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once US Deprescribing Research Network (USDeN) has new funding data
Product Launch: Get notified when US Deprescribing Research Network (USDeN) launches new products
Earning: See what the market has to say on US Deprescribing Research Network (USDeN) recently announced quarterly report
Check if US Deprescribing Research Network (USDeN) has recently received funding, and reach out quickly before it becomes old news!
Click to see if US Deprescribing Research Network (USDeN) had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at US Deprescribing Research Network (USDeN)
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined US Deprescribing Research Network (USDeN) as Masked Content
Find more new buyers
Compare Similar Companies to US Deprescribing Research Network (USDeN)
Compare insights from companies similar to US Deprescribing Research Network (USDeN), focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
US Deprescribing Research...
$14M
51-200
Private
-
2019
N/A
Company Profile Activity
Activity Insights
US Deprescribing Research Network (USDeN) is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
US Deprescribing Research Network (USDeN) is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about US Deprescribing Research Network (USDeN).
US Deprescribing Research Network (USDeN) Tech Stack
A closer look at the technologies used by US Deprescribing Research Network (USDeN)
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding US Deprescribing Research Network (USDeN)
Sign Up For FreeTo access detailed company insights
The US Deprescribing Research Network (USDeN) aims to enhance medication use and outcomes for older adults through research on deprescribing. Funded by the US National Institute on Aging, it brings together a community focused on improving evidence-based practices in this area. The network offers resources for clinicians and researchers, as well as... Read More
